EDGAR Filing Documents for 0001193125-04-089975

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-04-089975

Filing Date

2004-05-17

Accepted

2004-05-17 15:37:38

Documents

Period of Report

2004-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004	d10q.htm	10-Q	347113
2	AMENDMENT TO THE DEVELOPMENT AND SUPPLY AGREEMENT DATED MARCH 26, 2004	dex101.htm	EX-10.1	45841
3	CODE OF BUSINESS CONDUCT AND ETHICS	dex102.htm	EX-10.2	67747
4	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)	dex311.htm	EX-31.1	8833
5	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)	dex312.htm	EX-31.2	8591
6	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350	dex321.htm	EX-32.1	4258
7	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350	dex322.htm	EX-32.2	4274
	Complete submission text file	0001193125-04-089975.txt		489066

Mailing Address

Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200

XCYTE THERAPIES INC (Filer) CIK: 0001130166 (see all company filings)